531739 — Gennex Laboratories Balance Sheet
0.000.00%
Last trade - 00:00
- IN₹3.66bn
- IN₹3.65bn
- IN₹656.03m
- 44
- 20
- 80
- 44
R2019 March 31st | R2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | PRESS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 108 | 192 | 225 | 272 | 223 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 104 | 62.8 | 89.5 | 113 | 94.2 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 290 | 350 | 377 | 472 | 487 |
Net Property, Plant And Equipment | 156 | 149 | 141 | 137 | 676 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 517 | 569 | 589 | 680 | 1,323 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 173 | 209 | 190 | 242 | 295 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 179 | 213 | 192 | 242 | 520 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 338 | 357 | 397 | 438 | 803 |
Total Liabilities & Shareholders' Equity | 517 | 569 | 589 | 680 | 1,323 |
Total Common Shares Outstanding |